be_ixf;ym_202512 d_17; ct_50

Latest Insights on COUP

buy stocks omicron dip Buy the Omicron Dip! (But Choose Wisely) December 3, 2021 by Ted Bauman Big Picture. Big Profits., Investing Markets went haywire this week (and last) in response to a double whammy: Omicron’s appearance on the COVID stage and a suddenly hawkish Fed. Stocks dropped across the board … but some dropped more than others. That confirms what I’ve been saying for most of 2021: The market increasingly prefers quality and consistent earnings growth […]
Boeing 737 Max cleared in China for takeoff dog meme Boeing Bites Back; Whistling Tesla; Dolla Dolla General December 2, 2021 by Joseph Hargett Great Stuff A Flight Of Fancy On A Windswept Field Into the distance, a ribbon of sell-offs … stretched to the point of no turning back. Great Ones, I can’t keep my eyes from the circling sky today. Tongue-tied and twisted. Just an earthbound misfit, I … by golly, by gosh, I think Boeing’s (NYSE: ) learning […]
Quick Takes: This Tells Me "Stay Bullish!" Quick Takes: This Tells Me “Stay Bullish!” December 2, 2021 by Chad Shoop Bank It or Tank It, Quick Takes, Stocks, True Options Masters Chad is ignoring the headlines and sticking to what he knows: chart patterns. In today's Quick Takes, he's looking at TSLA, AMZN, FB, & more.
December's Market Outlook: Buy the Omicron Dip! December’s Market Outlook: Buy the Omicron Dip! December 1, 2021 by Chris Cimorelli Monthly Market Outlook, Trading Strategies, True Options Masters In the last Monthly Market Outlook of the year, your True Options Masters share actionable trade ideas to buy the omicron dip!
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Looks like I have finally found the right person to learn and grow from.”

- James

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This